ArticleJournal of clinical medicine2026

The Role of CD56 as an Immunophenotypic Marker in the Clinical Course of Multiple Myeloma.

Azat Karabekov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.